Phibro Animal Health | PAHC - Assets


Phibro Animal Health reported $1.45B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Align Technology USD 6.42B 103.41M Jun/2026
ANI Pharmaceuticals USD 1.42B 18.41M Mar/2026
Aurora Cannabis CAD 601.09M 174.2M Mar/2026
Bristol-Myers Squibb USD 87.63B 1.16B Jun/2026
Canopy Growth CAD 1.12B 12.54M Mar/2026
Corcept Therapeutics USD 888.7M 73.82M Jun/2026
Eli Lilly USD 116.58B 4.1B Mar/2026
Henry Schein USD 11.3B 89M Mar/2026
Idexx Laboratories USD 3.39B 34.74M Mar/2026
Knight Therapeutics CAD 1.05B 2.28M Dec/2025
Merck USD 128.68B 8.18B Mar/2026
Nektar Therapeutics USD 280.41M 20.94M Dec/2025
Pacira USD 1.21B 56.38M Mar/2026
Phibro Animal Health USD 1.45B 39.56M Mar/2026
Prestige Brands USD 3.49B 430K Mar/2026
Supernus Pharmaceuticals USD 1.5B 48.08M Mar/2026
Zoetis USD 15.15B 313M Mar/2026